Adenosine 5′-monophosphate increases levels of leukotrienes in breath condensate in asthma
Open Access
- 1 July 2004
- journal article
- research article
- Published by Elsevier in Respiratory Medicine
- Vol. 98 (7) , 651-655
- https://doi.org/10.1016/j.rmed.2003.12.011
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- PC20Adenosine 5 ′ -Monophosphate Is More Closely Associated with Airway Inflammation in Asthma Than PC20MethacholineAmerican Journal of Respiratory and Critical Care Medicine, 2001
- Exhaled Markers of Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2001
- Role of leukotrienes in asthma pathophysiologyPediatric Pulmonology, 2000
- Increased 8-Isoprostane, a Marker of Oxidative Stress, in Exhaled Condensate of Asthma PatientsAmerican Journal of Respiratory and Critical Care Medicine, 1999
- Histamine release upon adenosine 5'-monophosphate (AMP) nasal provocation in allergic subjectsThorax, 1999
- Increased urinary excretion of LTE4 after exercise and attenuation of exercise-induced bronchospasm by montelukast, a cysteinyl leukotriene receptor antagonistThorax, 1997
- Adenosine bronchoprovocation: a promising marker of allergic inflammation in asthma?Thorax, 1997
- Exhaled and nasal nitric oxide measurements: recommendations. The European Respiratory Society Task ForceEuropean Respiratory Journal, 1997
- Repeatability of cellular and soluble markers of inflammation in induced sputum from patients with asthmaEuropean Respiratory Journal, 1996
- Urinary leukotriene E4 in the assessment of nocturnal asthmaJournal of Allergy and Clinical Immunology, 1996